Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

DCB Bank - Gradually approaching normalcy - ICICI Securities

Posted On: 2021-01-24 22:17:00 (Time Zone: Arizona, USA)


DCB Bank's (DCB) Q3FY21 performance was characterised by balance sheet strengthening (built contingency buffer of Rs0.86bn), improving collections across segments, undisrupted focus on cost optimisation and calibrated approach in new business sourcing (disbursements up >50% QoQ). Notably, it remains committed to build a granular retail liability as reflect in strong Retail TD growth at 22% YoY and top-20 deposit share falling to 7.3% in Dec'20 from 9.3% in Mar'20. While uncertainty around incremental stressed asset formation persists, there has been a sharp reduction in the non-paying customer pool (now at 1-1.5% in LAP and home loan segment). This, in addition to a cumulative provision buffer of Rs5bn (~2% of net loans), improves visibility on DCB's superior management of its asset quality and credit cost vis--vis peers. Further, operating leverage and focus on achieving double-digit loan growth in FY22 and beyond, is likely to improve RoA to 1.1% by FY23. Maintain BUY with a revised target price of Rs144 (earlier: Rs140), valuing the stock at 1.1x FY23E P/BV. Key risks: 1) stress exceeding anticipated levels; and 2) delay in loan growth recovery.

- Asset quality (proforma) deteriorated; bank continued to build contingency buffer. While fresh slippages in Q3FY21 remained nil due to the Supreme Court's interim order, management disclosed proforma slippages at Rs4.4bn including potential restructured pool of Rs1.6bn and proforma GNPL at 3.7% (NNPL at 1.92%). Reported GNPA ratio improved to 1.96% while NNPA fell to 0.6%. DCB continued to strengthen its balance sheet by building additional provisions taking the total buffer to Rs5bn, or ~2% of loans. Collections in LAP and home loans improved to 90% and 94% respectively with the non- paying customer pool at 1-1.5%. Management estimates potential incremental restructuring of 3-5% in the coming quarters.

- Disbursement trend improving, but bank would continue to pursue calibrated growth. Deceleration in loan growth, which started in FY20, continued through Q3FY21. However, DCB is gradually getting back to rebuild new business momentum as reflected in the >50% QoQ growth in disbursements. While broad-based recovery in disbursements is likely to take some time, the bank targets double-digit growth in FY22 with emphasis on growing gold, home, tractor, business & MSME segments selectively.

- Cost rationalisation to continue. Management highlighted that the cost ratio at current level is not sustainable and is likely to increase with pick-up in business. However, over the medium term (next 18-24 months), it plans to reduce the cost/asset ratio to 2.2% from 2.4% in FY20. For the full year FY21, it expects total costs to decline 8-10% and NII to remain flat YoY. With margins likely to remain at the current level of ~3.75%, the desired steady-state RoA at 1.1 / 1.2% would be largely driven by operating leverage and normalised credit cost of 55-60bps vs 240bps in Q3FY21.

- Earnings revision. Factoring-in the improving collection trend and pick-up in disbursements, we increase our earnings estimates for FY21E and FY22E by 24% and 4% respectively by lowering our operating cost and credit cost assumptions.

Shares of DCB Bank Limited was last trading in BSE at Rs.116 as compared to the previous close of Rs. 117.7. The total number of shares traded during the day was 43542 in over 620 trades.

The stock hit an intraday high of Rs. 118.25 and intraday low of 114.75. The net turnover during the day was Rs. 5081385.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world

Initiating Coverage - Dalmia Bharat Ltd - HDFC Securities Retail Research Desk



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020